These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 911975)

  • 1. An example on the risk dependence and additivity of intensities in the theory of competing risks.
    Hakulinen T; Rahiala M
    Biometrics; 1977 Sep; 33(3):557-9. PubMed ID: 911975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review and critique of some models used in competing risk analysis.
    Gail M
    Biometrics; 1975 Mar; 31(1):209-22. PubMed ID: 1164533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent and competing disease risks: implications for host populations in variable environments.
    Jolles AE; Etienne RS; Olff H
    Am Nat; 2006 May; 167(5):745-57. PubMed ID: 16671018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gender more vulnerable.
    Basu AM
    Health Millions; 1991 Dec; 17(5):9-10. PubMed ID: 12317118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced rank proportional hazards model for competing risks.
    Fiocco M; Putter H; Van Houwelingen JC
    Biostatistics; 2005 Jul; 6(3):465-78. PubMed ID: 15831577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies.
    Montanez A; Ruskin JN; Hebert PR; Lamas GA; Hennekens CH
    Arch Intern Med; 2004 May; 164(9):943-8. PubMed ID: 15136301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when modelling mortality.
    Gregori D; Rosato R; Zecchin M; Baldi I; Di Lenarda A
    J Eval Clin Pract; 2008 Feb; 14(1):53-8. PubMed ID: 18211644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption, alcohol dependence, and all-cause mortality.
    Dawson DA
    Alcohol Clin Exp Res; 2000 Jan; 24(1):72-81. PubMed ID: 10656196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk cross sections and their application to risk estimation in the galactic cosmic-ray environment.
    Curtis SB; Nealy JE; Wilson JW
    Radiat Res; 1995 Jan; 141(1):57-65. PubMed ID: 7997515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic models with competing risks: methods and application to coronary risk prediction.
    Wolbers M; Koller MT; Witteman JC; Steyerberg EW
    Epidemiology; 2009 Jul; 20(4):555-61. PubMed ID: 19367167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of misclassification of the actual cause of death in competing risks analysis.
    Ebrahimi N
    Stat Med; 1996 Jul; 15(14):1557-66. PubMed ID: 8855481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
    Little MP; Hawkins MM; Charles MW; Hildreth NG
    Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonidentifiability aspect of the problem of competing risks.
    Tsiatis A
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):20-2. PubMed ID: 1054494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bounds on net survival probabilities for dependent competing risks.
    Klein JP; Moeschberger ML
    Biometrics; 1988 Jun; 44(2):529-38. PubMed ID: 3390509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between smoking and risk of esophageal cancer in 103 areas in China: a large-scale case-control study incorporated into a nationwide survey of mortality].
    Liu BQ; Jiang JM; Chen ZM; Chen JS; Zhang KL; Zeng XJ; Zhao P; Boreham J; Wu YP; Li JY; Peto R
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):380-5. PubMed ID: 16677545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Competitive risks and multi-state models in epidemiology].
    Commenges D
    Rev Epidemiol Sante Publique; 1999 Dec; 47(6):605-11. PubMed ID: 10673594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysing and interpreting competing risk data.
    Pintilie M
    Stat Med; 2007 Mar; 26(6):1360-7. PubMed ID: 16900575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.